Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
June 20, 2026Rinsho ShinkeigakuOpen Access

Metagenomic analysis for central nervous system infections: clinical utility and future directions

View Full Paper
Ask AI
Bookmark
Share

Authors

YSYusuke Sakiyama

Discussion

Loading...

Member takes

Overview

Randomized trial evaluates metagenomic sequencing for diagnosing neuroinfectious diseases, suggesting improved outcomes.

Key Points

  • This research aims to assess the clinical utility of metagenomic next-generation sequencing in diagnosing central nervous system infections.
  • Utilized metagenomic next-generation sequencing (mNGS) for comprehensive microbial analysis
  • Focused on cases of encephalitis and meningitis, particularly culture-negative and mixed infections
  • Evaluated diagnostic yield and pathogen detection in challenging clinical contexts.
  • mNGS improved diagnostic yield in challenging cases, identifying rare pathogens that conventional methods missed
  • Demonstrated effectiveness in culture-negative and anaerobic infections
  • Highlighted limitations like data volume and high costs, affecting universal applicability.

Cite This Study

Yusuke Sakiyama (2026) studied this question.

synapsesocial.com/papers/6a362e62db0793dc1a53628chttps://doi.org/10.5692/clinicalneurol.cn-002248
View Full Paper
Ask AI
Bookmark
Share